Nutrition-Related Outcomes for Autologous Stem Cell Transplantation Patients.


Journal

Clinical lymphoma, myeloma & leukemia
ISSN: 2152-2669
Titre abrégé: Clin Lymphoma Myeloma Leuk
Pays: United States
ID NLM: 101525386

Informations de publication

Date de publication:
07 2019
Historique:
received: 16 01 2019
revised: 21 03 2019
accepted: 01 04 2019
pubmed: 6 5 2019
medline: 5 8 2020
entrez: 5 5 2019
Statut: ppublish

Résumé

Autologous stem cell transplantation (ASCT) patients are at risk for malnutrition before transplantation admission as well as malnutrition acquired during their transplantation admission. In this retrospective, observational study we examined data related to consecutive adults (n = 330) admitted for ASCT between 2014 and 2016 at the Hospital of the University of Pennsylvania. Malnutrition risk on admission (identified by the Malnutrition Screening Tool) and transplantation-associated weight loss were analyzed for independent associations with hospital length of stay, nosocomial infection, intensive care unit transfer, deconditioning, time to platelet and neutrophil engraftment, 30-day readmission, and 1-year mortality. Adults with high malnutrition risk (n = 60) had a longer median hospital stay (P = .004), longer median time to platelet engraftment (P = .022), increased nosocomial infections (P = .047), and increased 1-year mortality (P = .036). Adults with high transplantation-associated weight loss (n = 100) experienced longer hospital stays (P < .001) and more intensive care unit transfers (P = .001). Outcomes for deconditioning, time to neutrophil engraftment, and 30-day readmission did not differ significantly on the basis of nutrition risk or weight loss. Further research is needed to determine whether early nutrition intervention would improve these outcomes.

Identifiants

pubmed: 31053549
pii: S2152-2650(19)30070-9
doi: 10.1016/j.clml.2019.04.002
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e393-e398

Subventions

Organisme : NCI NIH HHS
ID : T32 CA009492
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Heather Lazarow (H)

Hospital of the University of Pennsylvania, Philadelphia, PA. Electronic address: Heather.Lazarow@uphs.upenn.edu.

Michele Nicolo (M)

University of Southern California, Los Angeles, CA.

Charlene Compher (C)

University of Pennsylvania, School of Nursing, Philadelphia, PA.

Colleen R Kucharczuk (CR)

Hospital of the University of Pennsylvania, Philadelphia, PA.

Edward A Stadtmauer (EA)

Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, PA.

Daniel J Landsburg (DJ)

Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, PA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH